alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AS OF MARCH 31, 1998 AND THE STATEMENTS OF INCOME AND CASH FLOWS FOR
THE PERIOD ENDED MARCH 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FORM 10-Q QUARTERLY REPORT.
</LEGEND>
<CIK> 0000835715
<NAME> KU ENERGY CORPORATION
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               MAR-31-1998
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                    1,475,944
<OTHER-PROPERTY-AND-INVEST>                     50,509
<TOTAL-CURRENT-ASSETS>                         155,948
<TOTAL-DEFERRED-CHARGES>                        53,816
<OTHER-ASSETS>                                       0
<TOTAL-ASSETS>                               1,736,217
<COMMON>                                       308,137
<CAPITAL-SURPLUS-PAID-IN>                         (594)
<RETAINED-EARNINGS>                            364,966
<TOTAL-COMMON-STOCKHOLDERS-EQ>                 672,509
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     40,000
<LONG-TERM-DEBT-NET>                           546,330
<SHORT-TERM-NOTES>                                   0
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                       0
<LONG-TERM-DEBT-CURRENT-PORT>                       21
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                          0
<LEASES-CURRENT>                                     0
<OTHER-ITEMS-CAPITAL-AND-LIAB>                 477,357
<TOT-CAPITALIZATION-AND-LIAB>                1,736,217
<GROSS-OPERATING-REVENUE>                      183,210
<INCOME-TAX-EXPENSE>                            14,738
<OTHER-OPERATING-EXPENSES>                     135,776
<TOTAL-OPERATING-EXPENSES>                     150,514
<OPERATING-INCOME-LOSS>                         32,696
<OTHER-INCOME-NET>                               2,979
<INCOME-BEFORE-INTEREST-EXPEN>                  35,675
<TOTAL-INTEREST-EXPENSE>                        10,270
<NET-INCOME>                                    25,405
<PREFERRED-STOCK-DIVIDENDS>                          0
<EARNINGS-AVAILABLE-FOR-COMM>                   25,405
<COMMON-STOCK-DIVIDENDS>                        17,018
<TOTAL-INTEREST-ON-BONDS>                        9,289
<CASH-FLOW-OPERATIONS>                          75,396
<EPS-PRIMARY>                                      .67
<EPS-DILUTED>                                      .67
5 things to do RIGHT after visiting animals

1. Wet your hands with clean, running water 

2. Apply soap

3. Scrub hands well for 20 seconds. Backs of hands, between 

fingers, under fingernails.

4. Rinse hands

5. Dry hands with a clean paper towel or air dry them

www.cdc.gov/handwashing
#### § 540.46 Attorney visits.

Requirements for attorney visits are governed by the provisions on inmate legal activities (see §§ 543.12 through 543.16 of this chapter). Provisions pertinent to attorney visits for pretrial inmates are contained in § 551.117 of this chapter.

[68 FR 10658, Mar. 6, 2003]
grocery 

store

clinics

schoolS

workplace

Medical

Center

pediatrician’s

office

health

departmen

communit

center

drug

store

pharmacie

doctor’s

office

retail

stores

For more information, visit 

http://www.cdc.gov/flu 

Anyone can get the flu, and it can be serious. Every year, protect 

yourself and those around you by getting a flu vaccine.

CS226285-A

FOR OFFICE USE

There are many places

to get your flu vaccin
### §7604. Expiration of contact lens prescriptions

#### (a) In general

A contact lens prescription shall expire—

(1) on the date specified by the law of the State in which the prescription was written, if that date is one year or more after the issue date of the prescription;

(2) not less than one year after the issue date of the prescription if such State law specifies no date or a date that is less than one year after the issue date of the prescription; or

(3) notwithstanding paragraphs (1) and (2), on the date specified by the prescriber, if that date is based on the medical judgment of the prescriber with respect to the ocular health of the patient.

#### (b) Special rules for prescriptions of less than 1 year

If a prescription expires in less than 1 year, the reasons for the judgment referred to in subsection (a)(3) shall be documented in the patient's medical record. In no circumstance shall the prescription expiration date be less than the period of time recommended by the prescriber for a reexamination of the patient that is medically necessary.

#### (c) Definition

As used in this section, the term "issue date" means the date on which the patient receives a copy of the prescription.

(Pub. L. 108–164, §5, Dec. 6, 2003, 117 Stat. 2025.)

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Section effective 60 days after Dec. 6, 2003, see section 12 of Pub. L. 108–164, set out as a note under section 7601 of this title.
### §410ccc–21. Establishment

#### (a) In general

There is hereby established the Cane River National Heritage Area (hereinafter in this part referred to as the "heritage area").

#### (b) Purpose

In furtherance of the need to recognize the value and importance of the Cane River region and in recognition of the findings of section 410ccc(a) of this title, it is the purpose of this part to establish a heritage area to complement the historical park and to provide for a culturally sensitive approach to the preservation of the heritage of the Cane River region, and for other needs including—

(1) recognizing areas important to the Nation's heritage and identity;

(2) assisting in the preservation and enhancement of the cultural landscape and traditions of the Cane River region;

(3) providing a framework for those who live within this important dynamic cultural landscape to assist in preservation and educational actions; and

(4) minimizing the need for Federal land acquisition and management.

#### (c) Area included

The heritage area shall include—

(1) an area approximately 1 mile on both sides of the Cane River as depicted on map CARI, 80,000A, dated May 1994;

(2) those properties within the Natchitoches National Historic Landmark District which are the subject of cooperative agreements pursuant to section 410ccc–2(d) of this title;

(3) the Los Adaes State Commemorative Area;

(4) the Fort Jesup State Commemorative Area;

(5) the Fort St. Jean Baptiste State Commemorative Area; and

(6) the Kate Chopin House.

A final identification of all areas and sites to be included in the heritage area shall be included in the heritage area management plan as required in section 410ccc–23 of this title.

(Pub. L. 103–449, title IV, §401, Nov. 2, 1994, 108 Stat. 4760.)
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 97-6263

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

DANIEL A. VOGEL, JR.,

Defendant - Appellant.

Appeal from the United States District Court for the District of

South Carolina, at Charleston. David C. Norton, District Judge.

(CR-91-440, CA-96-170-2-18)

Submitted: May 29, 1998 Decided: June 30, 1998

Before MURNAGHAN and ERVIN, Circuit Judges, and PHILLIPS, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Susan Graham James, Montgomery, Alabama, for Appellant. Alfred

William Walker Bethea, Assistant United States Attorney, Florence,

South Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Appellant appeals the district court’s order denying his

motion filed under 28 U.S.C. § 2255 (1994) (current version at 28

U.S.C.A. § 2255 (West 1994 & Supp. 1998)). We have reviewed the

record and the district court’s opinion and find no reversible

error. Accordingly, we affirm on the reasoning of the district

court. United States v. Vogel, Nos. CR-91-440; CA-96-170-2-18

(D.S.C. Jan. 27, 1997). See Lindh v. Murphy, 521 U.S. ___, 1997 WL

338568 (U.S. June 23, 1997) (No. 96-6298). We grant the motion to

file a reply brief. We deny the motion for oral argument because

the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional

process.

AFFIRMED
#### § 550.57 Inmate appeals.

Inmates may seek formal review of complaints regarding the operation of the drug abuse treatment program by using administrative remedy procedures in 28 CFR part 542.
Exhibit 99.3



CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of CellStar Corporation
(the Registrant) on Form 10-K for the fiscal year ended November 30, 2002, filed with the Securities and Exchange Commission on February 28, 2003, as amended by the Form 10-K/A filed with the Securities and Exchange Commission on the
date hereof (the Report), the undersigned hereby certifies, in the capacity as indicated below and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his
knowledge:



| | 1. |  | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | -- |  | ---------------------------------------------------------------------------------------------------------------------------------



| | 2. |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| | -- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------



/s/ Robert
Kaiser

Robert Kaiser, Chief Financial Officer

Date: March 31, 2003



A signed original of this written statement required by Section 906 has been provided to CellStar Corporation and will be retained by CellStar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
#### Gilbert Haas, Appellant, v. Maurice Wertheim et al., Respondents.

(Appeal No. 2.)

No opinion. Hagarty, Carswell, Johnston, Adel and Taylor, JJ., concur.
ACCURIDE CORPORATION


CASH BONUS AGREEMENT - DIRECTOR


	
Name:

	
Name

	
Bonus Amount:

	
$


	 	 	 	 
	
Address:

	
Street


City State Zip

	
Payment Date:

	 
	 
	 	 	 	 
	 	 	 	 
	
Signature:

	 	 	 








Accuride Corporation (the "Company") will pay you the Bonus Amount set forth above if you are a member of the Board of Directors of the Company on the Payment Date set forth above.  If your service as a director terminates prior to the Payment Date for any reason, including resignation, removal or failure to be re-elected to the Board of Directors, you will forfeit the Bonus Amount. Notwithstanding the foregoing, if a Change in Control (as defined in the Company's 2010 Incentive Award Plan) occurs prior to the Payment Date, then the Bonus Amount will be paid upon a Change in Control.







The Bonus Amount or any interest or right therein or part thereof shall not be subject to disposition by transfer, alienation, anticipation, pledge, hypothecation, encumbrance, assignment or any other means, whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect.







The Company will deduct or withhold an amount sufficient to satisfy applicable federal, state, local and foreign taxes required by law to be withheld with respect to arising from the vesting and payment of the Bonus Amount.







Nothing in this Agreement shall be interpreted to confer upon you the right to continue as a director of the Company.







The Bonus Amount is discretionary and is a one-time benefit, which does not create any contractual or other right to receive future bonus opportunities or benefits in lieu thereof in the future. Future awards of bonus opportunities, if any, will be at the sole discretion of the Company, including, but not limited to, the timing of the award, the amount of the bonus and vesting provisions.







COMPANY:







ACCURIDE CORPORATION







	
By:


 


Its:

	
________________________________


Richard F. Dauch


President and Chief Executive Officer
Exhibit 10.42


 





AMENDMENT NO. 1 TO 


PATENT AND TECHNOLOGY LICENSE AGREEMENT


 


This Amendment No.
1 dated effective July 12, 2015 (the “Effective Date”)amends the Patent and Technology License Agreement (“Agreement”),
effective as of the 12th day of July, 2012 by and between Quick-Med Technologies, Inc., a Nevada corporation
having offices at 902 NW 4 Street, Gainesville, Florida 32601 and Derma Sciences, Inc., a Delaware corporation having offices
at 214 Carnegie Center, Suite 300, Princeton, New Jersey 08540 (each singularly a “Party” and collectively
the “Parties”).


 


WHEREAS, the parties
desire to amend the Agreement as set forth below;


 


NOW, THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties do hereby agree as follows:


 


1.Amendment.
Section 1.12 (Definitions; “Field”), is hereby amended to read in its entirety as follows:


 


“Field”
means Traditional Wound Care Products sold to the institutional market and the OTC/retail market, and products sold to the veterinary
and dental institutional market except for (i) mouth cotton and (ii) the Biosara 100% rayon products for sale to the sport medicine
and institutional market.  


 


2.Full
Force and Effect. Except for the terms and conditions expressly modified above, all other terms and conditions of the
Agreement shall remain unmodified and in full force and effect. 


 


IN WITNESS WHEREOF,
the Parties have caused this Amendment No. 1 to be executed by their duly authorized representatives as of the date first written
above.


 





	 	DERMA SCIENCES, INC.	 
	 	 	 	 
	 	 	 	 
	 	By:	/s/ Edward J. Quilty	 
	 	 	Edward J. Quilty	 
	 	 	President and Chief Executive Officer	 
	 	 	 	 
	 	 	 	 
	 	QUICK-MED TECHNOLOGIES, INC.	 
	 	 	 	 
	 	 	 	 
	 	By:	/s/ Bernd Liesenfeld	 
	 	 	Bernd Liesenfeld	 
	 	 	President	 


 






    	 	 -1-
HomeLatest FilingsPrevious Page

    - SEC Home  »
    - Search the Next-Generation EDGAR System  »
    - Company Search  »
    - Current Page

11100 SANTA MONICA BLVD.SUITE 2000LOS ANGELES CA 90025         

11100 SANTA MONICA BLVD.SUITE 2000LOS ANGELES CA 90025         310-235-5900

Crescent Private Credit Income Corp CIK#: 0001954360 (see all company filings)
State location: CA | State of Inc.: **MD** | Fiscal Year End: 1231Get **insider transactions** for this **issuer**.File Number: **812-15463**

||
||
#### § 5.305 Exemption under section 3(f) of the Act.

The exemption provided by section 3(f) of the Act shall not be available unless the President has, by publication in the Federal Register, designated for the purpose of this section the country the defense of which he deems vital to the defense of the United States.
NOTE: This order is nonprecedential.

mutteb ~tate~ qcourt of ~peaI~

for tbe jfeberaI qctrcutt

GERARDO c. AOANAN,

Claimant-Appellant,

v.

ERIC K. SHINSEKI, SECRETARY OF VETERANS

AFFAIRS,

Respondent-Appellee.

2012-7076

Appeal from the United States Court of Appeals for

Veterans Claims in case no. 08-3682, Judge Ronald M.

Holdaway.

ON MOTION

Before LOURIE, SCHALL and DYK, Circuit Judges.

PER CURIAM.

ORDER

Gerardo C. Aoanan moves for reconsideration of the

court's order dismissing his appeal as untimely filed.

Upon consideration thereof,
AOANAN v. SHINSEKI

IT Is ORDERED THAT:

The motion is denied.

DEC 11 2012

Date

cc: Gerardo C. Aoanan

Amanda L. Tantum, Esq.

s25

2

FOR THE COURT

/s/ Jan Horbaly

Jan Horbaly

Clerk

u.s. eouRf~1f3pEALS FOR .. THE FEDERAL r!RCUlT

DEC 1"I ~Ul~

JANHQRBAlY

a.ERK
|  |                      |
|--|----------------------|
|  | Home | Previous Page |

|  |  | Open Meeting of the SEC Advisory Committee on Improvements to Financial ReportingLocation:SEC HeadquartersAuditorium, Room L002Washington, D.C.Date:Thursday, August 2, 2007Time:10:00 A.M.Agenda- SEC Chairman Welcome and Introductory Remarks   
- Additional Opening Remarks and Introductions   
Conrad W. Hewitt, Chief Accountant
 
Robert Pozen, Committee Chair
 

- Presentation of  Discussion Paper   
- Comments on Discussion Paper   
- Conclusions and Next Steps   
- Adjourn (expected no later than 1 P.M.)   

 
*http://www.sec.gov/about/offices/oca/acifr/acifr-agenda-080207.htm*Home | Previous PageModified: 08/01/2007 |
|--|--|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
§ 42.405 Public dissemination of title VI information. ( a ) Federal agencies shall make available and, where appropriate, distribute their title VI regulations and guidelines for use by federal employees, applicants for federal assistance, recipients, beneficiaries and other interested persons.
( b ) State agency compliance programs (see § 42.410) shall be made available to the public.
( c ) Federal agencies shall require recipients, where feasible, to display prominently in reasonable numbers and places posters which state that the recipients operate programs subject to the nondiscrimination requirements of title VI, summarize those requirements, note the availability of title VI information from recipients and the federal agencies, and explain briefly the procedures for filing complaints. Federal agencies and recipients shall also include information on title VI requirements, complaint procedures and the rights of beneficiaries in handbooks, manuals, pamphlets and other material which are ordinarily distributed to the public to describe the federally assisted programs and the requirements for participation by recipients and beneficiaries. To the extent that recipients are required by law or regulation to publish or broadcast program information in the news media, federal agencies and recipients shall insure that such publications and broadcasts state that the program in question is an equal opportunity program or otherwise indicate that discrimination in the program is prohibited by federal law.
( d ) ( 1 ) Where a significant number or proportion of the population eligible to be served or likely to be directly affected by a federally assisted program (e.g., affected by relocation) needs service or information in a language other than English in order effectively to be informed of or to participate in the program, the recipient shall take reasonable steps, considering the scope of the program and the size and concentration of such population, to provide information in appropriate languages to such persons. This requirement applies with regard to written material of the type which is ordinarily distributed to the public.
( 2 ) Federal agencies shall also take reasonable steps to provide, in languages other than English, information regarding programs subject to title VI.
FROM: THE DISTRICT COURT OF THE THIRTEENTH JUDICIAL DISTRICT, COUNTY OF YELLOWSTONE,

#### STATE OF MONTANA, Plaintiff, vs. FRED W. SUTTON, Defendant.

NO. DC-89-223 DECISION

DATED this 6th day of December, 1990.

On February 13, 1990, the Defendant was sentenced to sixty (60) years for Deliberate Homicide; and was given credit for 286 days served.

On December 6, 1990, the Defendant’s application for review of that sentence was heard by the Sentence Review Division of the Montana Supreme Court.

The Defendant was present and was represented by Joylyn Smith, of the Montana Defender Project. The state was not represented.

Before hearing the application, the Defendant was advised that the Sentence Review Division has the authority not only to reduce the sentence or affirm it, but also to increase it if such is possible. The defendant was further advised that there is no appeal from a decision of the Sentence Review Division. The defendant acknowledged that he understood this and stated that he wished to proceed.

After careful consideration, it is the unanimous decision of the Sentence Review Division that the sentence imposed shall remain the same.

The reason for the decision is based upon Rule 17 of the Sentence Review Division.
Regulatory Evaluation 

Docket No. FAA- 1..-dl'<.- cfl<.f._O 

~ r'\ tu- c_f-o3o-AO ~~~~~(~ ~o ~ Directorate Identifier: -AD 

If you make changes to the values in the table below, you must ensure the totals update accordingly. If 

they do not, click (or Tab) into and then out of the changed cell. 

Estimated Costs: 

Action Costs per Product (e.g., aircraft, engine, 

(e.g., Inspection, propeller, appliance) 

replacement Work-hours Labor Parts Cost Total Costs Number of Total Cost ) 

Do not (include cost (labor + u.s. for U.S. Fleet include oncondition costs here access, testing, (@$85/h parts) Registered 

and close-up) our) Products 

Part I - Inspection 4.5 $50 21 

The known number of products in compliance: 0 

Total Costs of compliance for U.S. fleet: $9,083 

Costs covered under warranty (if known) $ 

On-Condition Costs: 

Action Work-hours Labor cost Parts Cost Cost per Product 

(e.g., Inspection, (include access, (@$85/hour) 

testing, and close- replacement) up) 

Part II3.0 $485 Replacement 

$0 

Special considerations for Economic Analysis (Use this field to explain anything in the Estimated Costs table 

that was assumed or might not be obvious. This field can also be used to explain warranty costs): Part I Inspection 

includes cleaning, inspecting, light sanding (if required), and applying a corrosion inhibitor to the 
parts. The estimated Replacement Parts Cost includes parts and shipping costs as follows: Fork 

End ($314), Spring ($106), Neoprene Sleeve ($15), and Consumables ($50). 

Executive Order 12866: 

Could the AD be considered a "significant regulatory action"? @ 

YES* D N0[2] 

*Explanation: 

DOT Regulatory Policies and Procedures: 

Is the AD significant? G 

YES* D N0[2] 

*Explanation: 

Regulatory Flexibility Act: 

Will the AD have a significant economic impact on a substantial number of small entities? Explain for 

either a Yes or No answer. G. 

YES D NO [2] 

Explanation: This AD will affect an estimated 21 U.S. registered aircraft. 

Intrastate Aviation in Alaska: 

This AD could affect intrastate aviation in Alaska. Is it appropriate to include specific reguirements for 

aircraft operated in Alaska where aviation might be the only mode of transportation? G 

YES* D N0[2] 

*Explanation: